Anemia can cause blurry vision through several distinct pathways, the most direct being oxygen starvation of the retina. When hemoglobin drops low enough, the delicate blood vessels at the back of the eye dilate, leak, and sometimes bleed, producing a condition called anemic retinopathy. But retinal bleeding is only one piece of the picture. Depending on the type and severity of anemia, the effects can range from subtle changes in retinal blood flow to optic nerve damage, raised pressure inside the skull, and even dry eyes that blur your view from the surface.
How Anemia Starves the Retina of Oxygen
The retina is one of the most metabolically active tissues in the body. It demands a constant, rich supply of oxygen, and hemoglobin is the molecule that delivers it. When hemoglobin levels fall, the retina enters a state of hypoxia. In response, retinal blood vessels dilate to try to push more blood through. That dilation raises the pressure inside the vessel walls and increases permeability, letting fluid and blood leak into surrounding tissue.
This chain of events produces the hallmark signs of anemic retinopathy. Localized patches of the nerve fiber layer lose their blood supply entirely, creating pale spots called cotton wool spots. Increased pressure on fragile vessel walls leads to hemorrhages at various depths of the retina. Fluid leaks into the retinal layers and causes swelling. When bleeding or swelling involves the macula, the central area responsible for sharp vision, you notice it as blurriness or a dim patch in the middle of your visual field.
The severity tends to track with how low hemoglobin goes and how quickly it drops. Acute, rapid-onset anemia is more likely to cause retinal problems than chronic anemia that develops slowly, because the eye has less time to adapt. Having a low platelet count on top of low hemoglobin makes things worse, since platelets are what normally plug small vessel leaks. In one study of patients with severe anemia and very low platelet counts, retinal hemorrhages were found in every single patient examined.
What Doctors See Inside the Eye
During a dilated eye exam, anemic retinopathy reveals a recognizable pattern. In a study of 38 eyes with anemic retinopathy, bleeding beneath the internal limiting membrane was the most common finding, present in about half of cases. Retinal hemorrhages appeared in roughly a fifth, followed by deeper bleeding, pale-centered hemorrhages known as Roth spots, optic disc pallor, hard exudates, and optic disc swelling.
Most of the time, anemic retinopathy produces no symptoms at all. You can have hemorrhages and cotton wool spots on the retina without knowing it, because they sit outside the macula. The trouble starts when bleeding or fluid accumulation hits the center of the retina, at which point you may experience blurred central vision, difficulty reading, or a noticeable dark area in your line of sight. In rare or prolonged cases, the optic nerve itself can be damaged.
Iron Deficiency and the Eyes
Iron deficiency anemia is the most common form of anemia worldwide, and it has its own particular relationship with vision. Beyond the general retinal changes shared by all anemias, iron deficiency can cause structural thinning of the retinal nerve fiber layer and measurable decreases in the density of tiny retinal blood vessels. These changes have been documented using advanced retinal imaging, though the findings are still being confirmed in larger studies.
One rare but serious complication specific to severe iron deficiency is retinal vascular occlusion, where a retinal artery or vein becomes blocked. This can cause sudden, dramatic vision loss in one eye. Cases of both branch retinal artery occlusion and central retinal vein occlusion have been reported as the first sign that a patient had severe iron deficiency anemia.
Iron deficiency also affects the front of the eye. Research has found that low serum iron levels correlate with reduced tear production and higher tear osmolarity, meaning drier, saltier tears. In infants with iron deficiency, tear volume was strongly linked to iron levels. Adolescents with thalassemia, a condition that disrupts hemoglobin production, showed significantly more dry eye symptoms and shorter tear film stability compared to healthy peers. Dry eyes cause fluctuating blurry vision because the tear film is the first optical surface light passes through. When it is unstable or insufficient, your vision wavers, especially during activities like reading or screen use.
Vitamin B12 Deficiency and the Optic Nerve
Vitamin B12 deficiency causes a different kind of vision problem. Rather than damaging the retinal blood vessels, B12 deficiency attacks the optic nerve itself, the cable that carries visual information from the eye to the brain. The resulting condition, optic neuropathy, typically presents as a gradual, painless decline in vision affecting both eyes.
In a systematic review that compiled 24 cases of B12 deficiency with eye involvement, the most common complaint was gradually worsening bilateral vision loss. In the majority of those cases, the eye symptoms were what first brought the patient to a doctor; they did not already know they were B12 deficient. Bilateral optic atrophy, where the optic nerve physically wastes away, was the most frequent diagnosis, found in about two-thirds of cases.
The encouraging news is that B12 optic neuropathy is often reversible if caught in time. In the reviewed cases, most patients received intramuscular B12 injections followed by oral supplementation, and vision improved. One case report described a 68-year-old man who had experienced months of deteriorating central vision in both eyes. After B12 replacement therapy, his vision recovered over the following months. The longer the deficiency persists before treatment, however, the less complete the recovery tends to be, because nerve fibers that have fully degenerated cannot grow back.
Pernicious anemia, an autoimmune condition that prevents B12 absorption, is one of the classic causes of this deficiency. Its typical presentation includes fatigue, pallor, tingling sensations, depression, and alterations to vision and smell. The vision changes can be the presenting symptom that leads to diagnosis, which makes it easy to confuse with a primary eye disease if the anemia is not suspected.
Sickle Cell Disease and the Retina
Sickle cell disease produces retinal problems through a mechanism distinct from simple oxygen deprivation. The abnormally shaped red blood cells in sickle cell disease are rigid and sticky. When they reach the tiny arterioles in the retina, they aggregate, slow down, and can block flow entirely. This leads to localized ischemia, and in severe cases, areas of the retina that lose blood supply permanently can trigger the growth of new, abnormal blood vessels, a condition called proliferative sickle retinopathy.
These fragile new vessels are prone to bleeding into the vitreous, the gel that fills the eye, which causes sudden vision loss. In advanced cases, scar tissue from the abnormal vessels can pull the retina away from the back of the eye, causing retinal detachment. More subtle damage can also occur in the central macula, where tiny areas of the middle retinal layers lose circulation. The practical consequence is that people with sickle cell disease need regular dilated eye exams even when their vision seems fine, because the most treatable stage of the disease is before symptoms appear.
When Anemia Raises Pressure Inside the Skull
A less obvious route from anemia to blurry vision runs through intracranial pressure. Severe anemia, particularly iron deficiency anemia, has been linked to idiopathic intracranial hypertension, a condition in which the pressure of the fluid surrounding the brain rises without an obvious structural cause. The elevated pressure pushes on the optic nerves where they enter the skull, causing them to swell. This swelling, called papilledema, blurs vision and can cause brief episodes of vision going dark, often triggered by bending over or standing up.
In a study of 153 patients with idiopathic intracranial hypertension, 22 had anemia, and the vast majority of them (19 out of 22) had iron deficiency anemia specifically. These patients tended to have a shorter disease course and responded well once both the anemia and the elevated pressure were treated. A separate case report described a 21-year-old woman with headaches and papilledema whose workup for other causes came up empty. When her severe anemia was corrected, the papilledema resolved and her vision improved.
The mechanism likely involves compensatory increases in cerebral blood flow in response to anemia-driven hypoxia. More blood flowing into the skull in a closed space can tip the balance of fluid pressures. This is worth knowing because the headaches and vision changes of intracranial hypertension can be misattributed to other causes if nobody checks a blood count.
Sudden Blackouts and Orthostatic Visual Loss
Some people with anemia notice their vision graying out or going briefly dark when they stand up quickly. This happens because anemia reduces the oxygen-carrying capacity of the blood, and when you stand, gravity temporarily pulls blood away from the brain. A healthy circulatory system compensates almost instantly, but when hemoglobin is low, there may not be enough oxygen in the blood reaching the brain and eyes during that brief lag. The result is transient visual dimming, sometimes progressing to near-blackout, that resolves within seconds once blood flow catches up.
In more extreme cases, the combination of anemia and orthostatic hypotension (a drop in blood pressure on standing) has been reported to cause more serious ischemic injury to the visual system. One case report described acute bilateral visual loss related to temporary hypoperfusion in a patient whose underlying anemia left little margin for any dip in blood pressure. This kind of event is rare, but it highlights why even brief, seemingly harmless vision changes on standing deserve attention if you are anemic.
How Anemia Makes Existing Eye Diseases Worse
Anemia does not just cause its own eye problems. It can accelerate eye diseases you already have. The clearest example is diabetic retinopathy. Diabetes damages retinal blood vessels over years, but anemia speeds the process dramatically by compounding the oxygen deficit. In one documented case, a patient’s vision deteriorated from normal to legal blindness within six months as background diabetic retinopathy progressed to severe proliferative disease. The accelerated course was attributed to moderate anemia resulting from leukemia and its treatment.
This interaction matters beyond that single case. If you have diabetes and develop anemia for any reason, whether from kidney disease, heavy periods, or a medication side effect, your retinal disease may worsen faster than expected. Eye doctors and primary care physicians do not always communicate about this overlap, so it is worth raising with both if you are managing diabetes alongside a condition that lowers hemoglobin.
Can Treatment Reverse the Eye Changes?
The answer depends on what kind of damage has occurred and how long it has been present. For many of the retinal changes caused by anemia, correcting the underlying blood counts leads to resolution. In aplastic anemia, one case documented near-complete spontaneous resolution of severe bilateral hemorrhagic retinopathy after the patient received a stem cell transplant. Over 16 weeks, the retinal bleeding cleared and vision significantly improved.
For iron deficiency specifically, parenteral iron therapy has been shown to increase both choroidal thickness and retinal nerve fiber layer thickness at all measured points, along with improvement in hematological parameters. These structural gains suggest that the retinal thinning seen in iron deficiency is at least partly reversible when iron stores are replenished.
B12 optic neuropathy, as discussed earlier, also responds to supplementation, though the window matters. If atrophy has already set in, the damage to nerve fibers may be permanent. Papilledema from anemia-related intracranial hypertension resolves with hemoglobin correction. And the transient vision dimming from orthostatic drops goes away once hemoglobin rises enough to restore adequate oxygen delivery.
The exceptions tend to involve structural damage: a retinal vein occlusion that has already destroyed photoreceptors, advanced proliferative sickle retinopathy with retinal detachment, or long-standing optic atrophy from untreated B12 deficiency. In those situations, the damage is done regardless of whether the anemia improves. This is why early detection matters. Many of these eye changes are silent until they hit the macula or optic nerve, which makes routine eye exams important for anyone with chronic or severe anemia.
Who Should Get an Eye Exam
Eye screening is not standard practice for most people with mild anemia, and it does not need to be. The risk of significant retinal findings rises with the severity of the anemia and the presence of additional risk factors. One study that examined the prevalence of retinopathy in anemic patients found that retinal hemorrhages were present in every patient who had both severe anemia and severe thrombocytopenia, and recommended routine fundus examinations for all such patients.
Beyond that high-risk group, the practical triggers for getting your eyes checked include any new visual symptoms (blurriness, floaters, dark spots, dimming on standing), a hemoglobin level that is significantly below normal rather than mildly low, anemia types associated with specific eye risks such as sickle cell disease or B12 deficiency, and the presence of other conditions like diabetes that independently threaten the retina. If your anemia is mild and you have no visual symptoms, the retina is likely fine. But if you notice anything off with your vision and you know your blood counts are low, mention both to your doctor rather than treating them as unrelated problems.
Aplastic Anemia and the Eye
Aplastic anemia deserves separate attention because it combines two of the strongest risk factors for retinal bleeding: low hemoglobin and very low platelets. In a retrospective study of 719 patients with idiopathic aplastic anemia, about a quarter of those who received retinal evaluations had retinal findings. The average hemoglobin in patients with retinal involvement was around 6.6 g/dL, well below normal, and their platelet counts were extremely low. Bilateral retinal hemorrhage was far more common than unilateral, and a central retinal vein occlusion-like picture appeared in nine patients.
Other ocular manifestations reported in aplastic anemia include eyelid and orbital hematomas, subconjunctival hemorrhage, and sudden vision loss from vitreous hemorrhage. The eye findings in aplastic anemia tend to be more dramatic than in other types of anemia precisely because the platelet deficit strips away the body’s ability to contain small bleeds. The encouraging pattern, consistent across case reports, is that when the bone marrow recovers (through transplant or immunosuppressive therapy), the eye findings tend to resolve along with the blood counts.